Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF7
|
ENSG00000081059.15 | transcription factor 7 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF7 | hg19_v2_chr5_+_133477868_133477885 | -0.59 | 3.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_+_68100989 | 4.41 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr8_+_133879193 | 4.38 |
ENST00000377869.1
ENST00000220616.4 |
TG
|
thyroglobulin |
chr2_-_217560248 | 4.36 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr8_-_119964434 | 3.70 |
ENST00000297350.4
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b |
chr4_-_186682716 | 3.44 |
ENST00000445343.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr1_-_79472365 | 3.37 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
chr10_+_99332198 | 3.05 |
ENST00000307518.5
ENST00000298808.5 ENST00000370655.1 |
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
chr2_+_234621551 | 3.01 |
ENST00000608381.1
ENST00000373414.3 |
UGT1A1
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A8 UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr1_-_16345245 | 2.87 |
ENST00000311890.9
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular) |
chr18_-_56296182 | 2.74 |
ENST00000361673.3
|
ALPK2
|
alpha-kinase 2 |
chr1_-_151345159 | 2.74 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr7_+_94023873 | 2.65 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr5_-_16936340 | 2.54 |
ENST00000507288.1
ENST00000513610.1 |
MYO10
|
myosin X |
chr14_+_85996471 | 2.50 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr1_+_169079823 | 2.49 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr2_-_151344172 | 2.42 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr7_-_107643567 | 2.37 |
ENST00000393559.1
ENST00000439976.1 ENST00000393560.1 |
LAMB1
|
laminin, beta 1 |
chr17_+_68101117 | 2.36 |
ENST00000587698.1
ENST00000587892.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr7_-_107643674 | 2.32 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
chr17_+_31255165 | 2.27 |
ENST00000578289.1
ENST00000439138.1 |
TMEM98
|
transmembrane protein 98 |
chr1_+_110009215 | 2.25 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr14_+_32798462 | 2.25 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr15_+_74466012 | 2.22 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr17_+_72428218 | 2.14 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr17_+_31255023 | 2.13 |
ENST00000395149.2
ENST00000261713.4 |
TMEM98
|
transmembrane protein 98 |
chr2_+_1417228 | 2.13 |
ENST00000382269.3
ENST00000337415.3 ENST00000345913.4 ENST00000346956.3 ENST00000349624.3 ENST00000539820.1 ENST00000329066.4 ENST00000382201.3 |
TPO
|
thyroid peroxidase |
chr14_+_32798547 | 2.13 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr7_+_73868439 | 2.10 |
ENST00000424337.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
chr8_+_70476088 | 2.09 |
ENST00000525999.1
|
SULF1
|
sulfatase 1 |
chrX_+_38420783 | 2.07 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr9_-_130639997 | 2.06 |
ENST00000373176.1
|
AK1
|
adenylate kinase 1 |
chr2_+_88367299 | 2.02 |
ENST00000419482.2
ENST00000444564.2 |
SMYD1
|
SET and MYND domain containing 1 |
chr1_-_116311323 | 1.97 |
ENST00000456138.2
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
chr14_+_85996507 | 1.96 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr2_-_242842587 | 1.95 |
ENST00000404031.1
|
AC131097.4
|
Protein LOC285095 |
chr2_+_88367368 | 1.93 |
ENST00000438570.1
|
SMYD1
|
SET and MYND domain containing 1 |
chr12_+_101988627 | 1.89 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr8_+_30244580 | 1.89 |
ENST00000523115.1
ENST00000519647.1 |
RBPMS
|
RNA binding protein with multiple splicing |
chr2_-_88427568 | 1.86 |
ENST00000393750.3
ENST00000295834.3 |
FABP1
|
fatty acid binding protein 1, liver |
chr12_+_101988774 | 1.83 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr20_+_57875457 | 1.82 |
ENST00000337938.2
ENST00000311585.7 ENST00000371028.2 |
EDN3
|
endothelin 3 |
chr2_+_69240302 | 1.81 |
ENST00000303714.4
|
ANTXR1
|
anthrax toxin receptor 1 |
chr15_-_93632421 | 1.75 |
ENST00000329082.7
|
RGMA
|
repulsive guidance molecule family member a |
chr17_+_72428266 | 1.74 |
ENST00000582473.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr17_+_48610074 | 1.72 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
chrX_-_15332665 | 1.71 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
chr2_-_86564776 | 1.68 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr5_-_36301984 | 1.67 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
chr9_-_35691017 | 1.65 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr7_+_140774032 | 1.63 |
ENST00000565468.1
|
TMEM178B
|
transmembrane protein 178B |
chr8_-_124665190 | 1.63 |
ENST00000325995.7
|
KLHL38
|
kelch-like family member 38 |
chr1_-_110933611 | 1.59 |
ENST00000472422.2
ENST00000437429.2 |
SLC16A4
|
solute carrier family 16, member 4 |
chr7_-_27213893 | 1.58 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
chr6_-_29527702 | 1.57 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr17_+_31254892 | 1.55 |
ENST00000394642.3
ENST00000579849.1 |
TMEM98
|
transmembrane protein 98 |
chr19_+_45281118 | 1.54 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr15_+_36871983 | 1.54 |
ENST00000437989.2
ENST00000569302.1 |
C15orf41
|
chromosome 15 open reading frame 41 |
chr10_-_61122220 | 1.53 |
ENST00000422313.2
ENST00000435852.2 ENST00000442566.3 ENST00000373868.2 ENST00000277705.6 ENST00000373867.3 ENST00000419214.2 |
FAM13C
|
family with sequence similarity 13, member C |
chr2_+_234580525 | 1.50 |
ENST00000609637.1
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr3_+_159570722 | 1.49 |
ENST00000482804.1
|
SCHIP1
|
schwannomin interacting protein 1 |
chr1_-_110933663 | 1.47 |
ENST00000369781.4
ENST00000541986.1 ENST00000369779.4 |
SLC16A4
|
solute carrier family 16, member 4 |
chr5_+_150040403 | 1.47 |
ENST00000517768.1
ENST00000297130.4 |
MYOZ3
|
myozenin 3 |
chr16_-_73082274 | 1.44 |
ENST00000268489.5
|
ZFHX3
|
zinc finger homeobox 3 |
chr2_+_189157536 | 1.44 |
ENST00000409580.1
ENST00000409637.3 |
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
chr5_+_147648393 | 1.43 |
ENST00000511106.1
ENST00000398450.4 |
SPINK13
|
serine peptidase inhibitor, Kazal type 13 (putative) |
chr5_+_140235469 | 1.41 |
ENST00000506939.2
ENST00000307360.5 |
PCDHA10
|
protocadherin alpha 10 |
chr11_-_8615488 | 1.41 |
ENST00000315204.1
ENST00000396672.1 ENST00000396673.1 |
STK33
|
serine/threonine kinase 33 |
chr6_+_125540951 | 1.41 |
ENST00000524679.1
|
TPD52L1
|
tumor protein D52-like 1 |
chr2_+_108994633 | 1.38 |
ENST00000409309.3
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4 |
chr11_-_8615687 | 1.38 |
ENST00000534493.1
ENST00000422559.2 |
STK33
|
serine/threonine kinase 33 |
chr11_-_8615720 | 1.38 |
ENST00000358872.3
ENST00000454443.2 |
STK33
|
serine/threonine kinase 33 |
chr10_+_52750930 | 1.36 |
ENST00000401604.2
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
chr1_+_185703513 | 1.35 |
ENST00000271588.4
ENST00000367492.2 |
HMCN1
|
hemicentin 1 |
chr1_+_22138758 | 1.33 |
ENST00000344642.2
ENST00000543870.1 |
LDLRAD2
|
low density lipoprotein receptor class A domain containing 2 |
chr2_-_238499337 | 1.29 |
ENST00000411462.1
ENST00000409822.1 |
RAB17
|
RAB17, member RAS oncogene family |
chr11_+_100862811 | 1.29 |
ENST00000303130.2
|
TMEM133
|
transmembrane protein 133 |
chr5_-_137610300 | 1.28 |
ENST00000274721.3
|
GFRA3
|
GDNF family receptor alpha 3 |
chr2_+_234580499 | 1.28 |
ENST00000354728.4
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr3_+_14860469 | 1.28 |
ENST00000285046.5
|
FGD5
|
FYVE, RhoGEF and PH domain containing 5 |
chr3_+_178276488 | 1.28 |
ENST00000432997.1
ENST00000455865.1 |
KCNMB2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
chr2_-_86564740 | 1.27 |
ENST00000540790.1
ENST00000428491.1 |
REEP1
|
receptor accessory protein 1 |
chr20_+_39969519 | 1.26 |
ENST00000373257.3
|
LPIN3
|
lipin 3 |
chr15_+_36871806 | 1.26 |
ENST00000566621.1
ENST00000564586.1 |
C15orf41
|
chromosome 15 open reading frame 41 |
chr5_-_137610254 | 1.25 |
ENST00000378362.3
|
GFRA3
|
GDNF family receptor alpha 3 |
chr2_-_179659669 | 1.25 |
ENST00000436599.1
|
TTN
|
titin |
chr7_-_16840820 | 1.25 |
ENST00000450569.1
|
AGR2
|
anterior gradient 2 |
chr7_+_134576317 | 1.24 |
ENST00000424922.1
ENST00000495522.1 |
CALD1
|
caldesmon 1 |
chr7_+_134576151 | 1.24 |
ENST00000393118.2
|
CALD1
|
caldesmon 1 |
chr18_+_6729698 | 1.23 |
ENST00000383472.4
|
ARHGAP28
|
Rho GTPase activating protein 28 |
chr2_+_159651821 | 1.21 |
ENST00000309950.3
ENST00000409042.1 |
DAPL1
|
death associated protein-like 1 |
chr7_-_135433534 | 1.21 |
ENST00000338588.3
|
FAM180A
|
family with sequence similarity 180, member A |
chr8_-_17579726 | 1.18 |
ENST00000381861.3
|
MTUS1
|
microtubule associated tumor suppressor 1 |
chr6_+_43968306 | 1.18 |
ENST00000442114.2
ENST00000336600.5 ENST00000439969.2 |
C6orf223
|
chromosome 6 open reading frame 223 |
chr11_+_7506584 | 1.18 |
ENST00000530135.1
|
OLFML1
|
olfactomedin-like 1 |
chr17_+_48611853 | 1.17 |
ENST00000507709.1
ENST00000515126.1 ENST00000507467.1 |
EPN3
|
epsin 3 |
chr7_+_55086703 | 1.16 |
ENST00000455089.1
ENST00000342916.3 ENST00000344576.2 ENST00000420316.2 |
EGFR
|
epidermal growth factor receptor |
chr14_-_23624511 | 1.16 |
ENST00000529705.2
|
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr18_-_24445729 | 1.15 |
ENST00000383168.4
|
AQP4
|
aquaporin 4 |
chr21_+_17553910 | 1.13 |
ENST00000428669.2
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr3_-_167813672 | 1.13 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
chr17_+_75542997 | 1.11 |
ENST00000592651.1
ENST00000590398.1 |
RP11-13K12.1
|
RP11-13K12.1 |
chr7_+_23286182 | 1.11 |
ENST00000258733.4
ENST00000381990.2 ENST00000409458.3 ENST00000539136.1 ENST00000453162.2 |
GPNMB
|
glycoprotein (transmembrane) nmb |
chr6_-_112575687 | 1.10 |
ENST00000521398.1
ENST00000424408.2 ENST00000243219.3 |
LAMA4
|
laminin, alpha 4 |
chr2_-_238499303 | 1.10 |
ENST00000409576.1
|
RAB17
|
RAB17, member RAS oncogene family |
chr2_+_220309379 | 1.10 |
ENST00000451076.1
|
SPEG
|
SPEG complex locus |
chr10_-_69455873 | 1.09 |
ENST00000433211.2
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3 |
chr5_+_140579162 | 1.09 |
ENST00000536699.1
ENST00000354757.3 |
PCDHB11
|
protocadherin beta 11 |
chr6_+_112408768 | 1.09 |
ENST00000368656.2
ENST00000604268.1 |
FAM229B
|
family with sequence similarity 229, member B |
chr6_-_112575912 | 1.09 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr10_+_54074033 | 1.08 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
chrX_-_117119243 | 1.08 |
ENST00000539496.1
ENST00000469946.1 |
KLHL13
|
kelch-like family member 13 |
chr10_-_61513201 | 1.07 |
ENST00000414264.1
ENST00000594536.1 |
LINC00948
|
long intergenic non-protein coding RNA 948 |
chr13_+_36920569 | 1.07 |
ENST00000379848.2
|
SPG20OS
|
SPG20 opposite strand |
chr2_+_155555201 | 1.04 |
ENST00000544049.1
|
KCNJ3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
chr1_+_59762642 | 1.03 |
ENST00000371218.4
ENST00000303721.7 |
FGGY
|
FGGY carbohydrate kinase domain containing |
chr13_+_30002741 | 1.01 |
ENST00000380808.2
|
MTUS2
|
microtubule associated tumor suppressor candidate 2 |
chr10_+_75668916 | 1.00 |
ENST00000481390.1
|
PLAU
|
plasminogen activator, urokinase |
chr9_-_21187598 | 1.00 |
ENST00000421715.1
|
IFNA4
|
interferon, alpha 4 |
chr19_+_13135439 | 1.00 |
ENST00000586873.1
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr11_-_8615507 | 0.99 |
ENST00000431279.2
ENST00000418597.1 |
STK33
|
serine/threonine kinase 33 |
chr5_+_140705777 | 0.99 |
ENST00000606901.1
ENST00000606674.1 |
AC005618.6
|
AC005618.6 |
chr3_+_35681728 | 0.98 |
ENST00000421492.1
ENST00000458225.1 ENST00000337271.5 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr5_+_34757309 | 0.98 |
ENST00000397449.1
|
RAI14
|
retinoic acid induced 14 |
chr5_+_140165876 | 0.97 |
ENST00000504120.2
ENST00000394633.3 ENST00000378133.3 |
PCDHA1
|
protocadherin alpha 1 |
chr11_+_7506713 | 0.97 |
ENST00000329293.3
ENST00000534244.1 |
OLFML1
|
olfactomedin-like 1 |
chr4_+_69917078 | 0.97 |
ENST00000502942.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr12_+_108523133 | 0.97 |
ENST00000547525.1
|
WSCD2
|
WSC domain containing 2 |
chr2_-_172750733 | 0.96 |
ENST00000392592.4
ENST00000422440.2 |
SLC25A12
|
solute carrier family 25 (aspartate/glutamate carrier), member 12 |
chr22_+_39052632 | 0.96 |
ENST00000411557.1
ENST00000396811.2 ENST00000216029.3 ENST00000416285.1 |
CBY1
|
chibby homolog 1 (Drosophila) |
chr22_+_29279552 | 0.96 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
chr10_+_19777984 | 0.95 |
ENST00000377265.3
ENST00000455457.2 |
C10orf112
|
MAM and LDL receptor class A domain containing 1 |
chr1_+_244998918 | 0.93 |
ENST00000366528.3
|
COX20
|
COX20 cytochrome C oxidase assembly factor |
chr19_+_50084561 | 0.93 |
ENST00000246794.5
|
PRRG2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
chr4_+_154125565 | 0.93 |
ENST00000338700.5
|
TRIM2
|
tripartite motif containing 2 |
chr11_+_7506837 | 0.93 |
ENST00000528758.1
|
OLFML1
|
olfactomedin-like 1 |
chr2_-_241195452 | 0.92 |
ENST00000457178.1
|
AC124861.1
|
AC124861.1 |
chr18_+_32455201 | 0.92 |
ENST00000590831.2
|
DTNA
|
dystrobrevin, alpha |
chr1_-_155162658 | 0.92 |
ENST00000368389.2
ENST00000368396.4 ENST00000343256.5 ENST00000342482.4 ENST00000368398.3 ENST00000368390.3 ENST00000337604.5 ENST00000368392.3 ENST00000438413.1 ENST00000368393.3 ENST00000457295.2 ENST00000338684.5 ENST00000368395.1 |
MUC1
|
mucin 1, cell surface associated |
chr1_-_213020991 | 0.92 |
ENST00000332912.3
|
C1orf227
|
chromosome 1 open reading frame 227 |
chr1_-_209824643 | 0.91 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr11_-_57092381 | 0.90 |
ENST00000358252.3
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr3_+_35681081 | 0.89 |
ENST00000428373.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr2_-_231989808 | 0.89 |
ENST00000258400.3
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
chr6_+_32146131 | 0.89 |
ENST00000375094.3
|
RNF5
|
ring finger protein 5, E3 ubiquitin protein ligase |
chr14_+_21214039 | 0.88 |
ENST00000326842.2
|
EDDM3A
|
epididymal protein 3A |
chr13_+_102104952 | 0.87 |
ENST00000376180.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr1_-_153029980 | 0.87 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr10_+_52833883 | 0.85 |
ENST00000373980.4
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
chr19_+_41256764 | 0.85 |
ENST00000243563.3
ENST00000601253.1 ENST00000597353.1 ENST00000599362.1 |
SNRPA
|
small nuclear ribonucleoprotein polypeptide A |
chr8_+_95653840 | 0.85 |
ENST00000520385.1
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr4_+_95972822 | 0.84 |
ENST00000509540.1
ENST00000440890.2 |
BMPR1B
|
bone morphogenetic protein receptor, type IB |
chr6_-_25874440 | 0.84 |
ENST00000361703.6
ENST00000397060.4 |
SLC17A3
|
solute carrier family 17 (organic anion transporter), member 3 |
chr4_+_87515454 | 0.82 |
ENST00000427191.2
ENST00000436978.1 ENST00000502971.1 |
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
chr4_-_52904425 | 0.82 |
ENST00000535450.1
|
SGCB
|
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
chr22_-_39052300 | 0.82 |
ENST00000355830.6
|
FAM227A
|
family with sequence similarity 227, member A |
chr13_+_102142296 | 0.80 |
ENST00000376162.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr17_+_53343171 | 0.80 |
ENST00000430986.2
|
HLF
|
hepatic leukemia factor |
chr6_-_112575758 | 0.78 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
chr6_+_43265992 | 0.78 |
ENST00000449231.1
ENST00000372589.3 ENST00000372585.5 |
SLC22A7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr5_-_160365601 | 0.78 |
ENST00000518580.1
ENST00000518301.1 |
RP11-109J4.1
|
RP11-109J4.1 |
chr10_-_99393208 | 0.77 |
ENST00000307450.6
|
MORN4
|
MORN repeat containing 4 |
chr12_+_6309963 | 0.76 |
ENST00000382515.2
|
CD9
|
CD9 molecule |
chrX_-_138287168 | 0.76 |
ENST00000436198.1
|
FGF13
|
fibroblast growth factor 13 |
chr2_-_99871570 | 0.75 |
ENST00000333017.2
ENST00000409679.1 ENST00000423306.1 |
LYG2
|
lysozyme G-like 2 |
chr1_+_244998602 | 0.74 |
ENST00000411948.2
|
COX20
|
COX20 cytochrome C oxidase assembly factor |
chr1_-_75198940 | 0.74 |
ENST00000417775.1
|
CRYZ
|
crystallin, zeta (quinone reductase) |
chr16_-_8622226 | 0.74 |
ENST00000568335.1
|
TMEM114
|
transmembrane protein 114 |
chr8_-_6914251 | 0.73 |
ENST00000330590.2
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific |
chr7_-_135433460 | 0.73 |
ENST00000415751.1
|
FAM180A
|
family with sequence similarity 180, member A |
chr1_-_75198495 | 0.73 |
ENST00000441120.1
|
CRYZ
|
crystallin, zeta (quinone reductase) |
chr17_-_63557309 | 0.73 |
ENST00000580513.1
|
AXIN2
|
axin 2 |
chr19_-_49339080 | 0.73 |
ENST00000595764.1
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14 |
chrX_+_102883620 | 0.73 |
ENST00000372626.3
|
TCEAL1
|
transcription elongation factor A (SII)-like 1 |
chr1_+_68150744 | 0.73 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
chr7_-_36406750 | 0.72 |
ENST00000453212.1
ENST00000415803.2 ENST00000440378.1 ENST00000431396.1 ENST00000317020.6 ENST00000436884.1 |
KIAA0895
|
KIAA0895 |
chr1_-_75198681 | 0.72 |
ENST00000370872.3
ENST00000370871.3 ENST00000340866.5 ENST00000370870.1 |
CRYZ
|
crystallin, zeta (quinone reductase) |
chr17_+_48503519 | 0.71 |
ENST00000300441.4
ENST00000541920.1 ENST00000506582.1 ENST00000504392.1 ENST00000427954.2 |
ACSF2
|
acyl-CoA synthetase family member 2 |
chr10_+_115999089 | 0.71 |
ENST00000392982.3
|
VWA2
|
von Willebrand factor A domain containing 2 |
chr8_-_42358742 | 0.71 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr17_+_53343577 | 0.71 |
ENST00000573945.1
|
HLF
|
hepatic leukemia factor |
chr11_-_64013288 | 0.71 |
ENST00000542235.1
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr2_+_166326157 | 0.70 |
ENST00000421875.1
ENST00000314499.7 ENST00000409664.1 |
CSRNP3
|
cysteine-serine-rich nuclear protein 3 |
chr17_-_63556414 | 0.68 |
ENST00000585045.1
|
AXIN2
|
axin 2 |
chr3_-_169487617 | 0.67 |
ENST00000330368.2
|
ACTRT3
|
actin-related protein T3 |
chr12_+_27677085 | 0.67 |
ENST00000545334.1
ENST00000540114.1 ENST00000537927.1 ENST00000318304.8 ENST00000535047.1 ENST00000542629.1 ENST00000228425.6 |
PPFIBP1
|
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
chr9_+_109685630 | 0.67 |
ENST00000451160.2
|
RP11-508N12.4
|
Uncharacterized protein |
chr4_-_85419603 | 0.67 |
ENST00000295886.4
|
NKX6-1
|
NK6 homeobox 1 |
chr10_-_62332357 | 0.66 |
ENST00000503366.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
chr19_+_13135386 | 0.65 |
ENST00000360105.4
ENST00000588228.1 ENST00000591028.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr10_+_104629199 | 0.65 |
ENST00000369880.3
|
AS3MT
|
arsenic (+3 oxidation state) methyltransferase |
chr11_-_76155618 | 0.65 |
ENST00000530759.1
|
RP11-111M22.3
|
RP11-111M22.3 |
chr2_+_177134201 | 0.65 |
ENST00000452865.1
|
MTX2
|
metaxin 2 |
chr12_-_130529501 | 0.65 |
ENST00000561864.1
ENST00000567788.1 |
RP11-474D1.4
RP11-474D1.3
|
RP11-474D1.4 RP11-474D1.3 |
chr7_-_143929936 | 0.64 |
ENST00000391496.1
|
OR2A42
|
olfactory receptor, family 2, subfamily A, member 42 |
chr6_+_54172653 | 0.63 |
ENST00000370869.3
|
TINAG
|
tubulointerstitial nephritis antigen |
chr2_+_108994466 | 0.63 |
ENST00000272452.2
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4 |
chr12_-_71003568 | 0.62 |
ENST00000547715.1
ENST00000451516.2 ENST00000538708.1 ENST00000550857.1 ENST00000261266.5 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr20_+_57875658 | 0.62 |
ENST00000371025.3
|
EDN3
|
endothelin 3 |
chr9_+_113431029 | 0.62 |
ENST00000189978.5
ENST00000374448.4 ENST00000374440.3 |
MUSK
|
muscle, skeletal, receptor tyrosine kinase |
chr14_-_21502944 | 0.61 |
ENST00000382951.3
|
RNASE13
|
ribonuclease, RNase A family, 13 (non-active) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.2 | 3.7 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.9 | 4.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.9 | 4.5 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.7 | 4.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 1.8 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.5 | 4.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.5 | 2.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.5 | 1.4 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.5 | 1.4 | GO:0090381 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.4 | 2.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 2.5 | GO:1903281 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 2.4 | GO:0014826 | cellular magnesium ion homeostasis(GO:0010961) vein smooth muscle contraction(GO:0014826) |
0.3 | 4.4 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.3 | 2.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.9 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.3 | 1.2 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.3 | 1.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 1.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.9 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.2 | 5.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 1.3 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.2 | 1.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.0 | GO:2000051 | Wnt receptor catabolic process(GO:0038018) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 1.2 | GO:1903899 | lung goblet cell differentiation(GO:0060480) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 0.5 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.2 | 2.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.2 | 3.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 2.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 1.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 2.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.5 | GO:0003193 | pulmonary valve formation(GO:0003193) visceral motor neuron differentiation(GO:0021524) foramen ovale closure(GO:0035922) |
0.1 | 0.9 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 1.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 2.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.5 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.1 | 0.8 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 2.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.6 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 0.7 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 4.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 2.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 6.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.7 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.5 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 2.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 3.4 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 1.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 2.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 1.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 1.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.6 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.9 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 1.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 1.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.1 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.0 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 1.6 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 1.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.5 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.8 | GO:0030913 | fusion of sperm to egg plasma membrane(GO:0007342) paranodal junction assembly(GO:0030913) |
0.0 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.0 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 1.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.0 | 1.1 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 1.1 | GO:0042692 | muscle cell differentiation(GO:0042692) |
0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 1.2 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.0 | 1.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 2.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.5 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 2.3 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 4.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 1.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 1.8 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 1.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 1.5 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 2.9 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.5 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 1.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 2.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 1.1 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.0 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.2 | GO:0019627 | urea metabolic process(GO:0019627) |
0.0 | 0.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.9 | 2.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.4 | 4.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.2 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.4 | 6.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 3.0 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 4.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 4.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.9 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 3.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 4.4 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 2.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 3.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 2.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 4.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 3.0 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 1.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 7.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 3.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 4.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.3 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 6.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 7.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 3.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.0 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 2.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 2.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.4 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.7 | 2.9 | GO:1990175 | EH domain binding(GO:1990175) |
0.5 | 3.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 2.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 3.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.4 | 2.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 1.0 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.3 | 2.2 | GO:0070404 | NADH binding(GO:0070404) |
0.3 | 4.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 2.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.3 | 0.9 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.3 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 6.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 2.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 2.6 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 1.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 2.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 4.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 4.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 3.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.9 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 2.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 6.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 2.7 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.5 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 1.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 2.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 1.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 1.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.2 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.1 | 2.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.1 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 3.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 1.1 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 8.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 4.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 1.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.0 | 0.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 1.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 1.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 2.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 4.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 1.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 9.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.7 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 3.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 3.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 3.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 5.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 6.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 5.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 2.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 1.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 7.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.7 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 1.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |